Niu, Jun-Ying <br/><br/>
Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.  [electronic resource] 

 -  Annals of hematology  Oct 2018 
 - 1841-1849 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-018-3382-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Area Under Curve<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Fibrinogen--analysis<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lymphoma, Large B-Cell, Diffuse--blood<br/>Male<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Proportional Hazards Models<br/>ROC Curve<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Rituximab--administration & dosage<br/>Severity of Illness Index<br/>Vincristine--administration & dosage